SEC 13F Intelligence

Capital Analysts, LLC / ABT

Capital Analysts, LLC’s Abbott Laboratories Position

Does Capital Analysts, LLC own Abbott Laboratories (ABT)? Yes — 115.9K shares worth $12M (+0.31% of its 13F portfolio) as of Q1 2026, up from 112.2K shares the prior filed quarter.

Position Value
$12M
Q1 2026
Shares
115.9K
% of Portfolio
+0.31%
Quarters Held
30
currently held

Position History ABT

Reported value by quarter
Q4 ’18: $5MQ4 ’18Q1 ’19: $5MQ2 ’19: $5MQ3 ’19: $4MQ4 ’19: $4MQ4 ’19Q1 ’20: $4MQ2 ’20: $4MQ3 ’20: $5MQ4 ’20: $5MQ4 ’20Q1 ’21: $6MQ2 ’21: $6MQ3 ’21: $6MQ4 ’21: $7MQ4 ’21Q1 ’22: $6MQ2 ’22: $6MQ3 ’22: $6MQ4 ’22: $7MQ4 ’22Q1 ’23: $7MQ2 ’23: $8MQ3 ’23: $7MQ4 ’23: $9MQ4 ’23Q1 ’24: $9MQ2 ’24: $9MQ3 ’24: $10MQ4 ’24: $10MQ4 ’24Q1 ’25: $12MQ2 ’25: $14MQ3 ’25: $14MQ4 ’25: $14MQ4 ’25Q1 ’26: $12Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026115.9K$12M+0.31%
Q4 2025112.2K$14M+0.39%
Q3 2025106.9K$14M+0.42%
Q2 202599.5K$14M+0.45%
Q1 202593.7K$12M+0.46%
Q4 202488.7K$10M+0.40%
Q3 202485.4K$10M+0.40%
Q2 202483.1K$9M+0.38%
Q1 202479.5K$9M+0.42%
Q4 202378.5K$9M+0.44%
Q3 202376.5K$7M+0.41%
Q2 202370.1K$8M+0.42%
Q1 202365.9K$7M+0.38%
Q4 202262.5K$7M+0.42%
Q3 202260.2K$6M+0.40%
Q2 202256.1K$6M+0.42%
Q1 202253.8K$6M+0.40%
Q4 202151.2K$7M+0.44%
Q3 202149.5K$6M+0.38%
Q2 202148.6K$6M+0.38%
Q1 202147.6K$6M+0.39%
Q4 202048.1K$5M+0.46%
Q3 202047.3K$5M+0.49%
Q2 202048.6K$4M+0.47%
Q1 202051.1K$4M+0.49%
Q4 201950.0K$4M+0.43%
Q3 201949.4K$4M+0.44%
Q2 201958.4K$5M+0.54%
Q1 201961.6K$5M+0.57%
Q4 201864.0K$5M+0.61%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Capital Analysts, LLC’s full portfolio or all institutional holders of ABT.